Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05411393 · ClinicalTrials.gov registry record · NA

Synergizing Home Health Rehabilitation Therapy

A NA study of Frailty and Rehabilitation, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
47
Enrollment target
1
Study location

NCT05411393: Completed NA study of Frailty and Rehabilitation, sponsored by University of Florida.

NCT05411393 is a NA study of Frailty and Rehabilitation that has completed, run by University of Florida. The registered enrollment target is 47 participants, below the 1,505-participant average among 48 other Frailty trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05411393, a NA study of Frailty and Rehabilitation, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
47 participants
Enrollment target
1
Study location

Study Summary

The objective of this project is to pilot test an ADL (activities of daily living)-enhanced program as an adjuvant therapy to usual home health rehabilitation to improve patient outcomes. The project will compare the ADL-enhanced program plus usual care with usual care using an RCT design in home health patients.

Primary Outcome

The Motor Skills score is a subscale in the Assessment of Motor and Process Skills, which evaluates the degree of motor performance when an individual performs a challenging daily activity. The score range of the subscale ranges from -3 to +4. A higher score indicates better motor performance.

Interventions

  • OTHER ADL-enhanced program
  • OTHER Usual home health rehabilitation therapy

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2022-10-06
Est. Completion 2025-03-15
Phase NA
University of Florida

1,106 total trials

What the finished NCT05411393 record still lists

NCT05411393 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 1,505-participant average among 48 other Frailty trials with a reported enrollment target (97% lower).

The record links to 10 conditions, with Frailty appearing as the primary indexed condition, and to 2 interventions - of which ADL-enhanced program is the first listed.

NCT05411393 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT05411393 about?

NCT05411393 is a clinical study titled "Synergizing Home Health Rehabilitation Therapy". The objective of this project is to pilot test an ADL (activities of daily living)-enhanced program as an adjuvant therapy to usual home health rehabilitation to improve patient outcomes. The project will compare the ADL-enhanced program plus usual care with usual care using an RCT design in home he...

What is the current status of trial NCT05411393?

This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2022-10-06. Estimated completion is 2025-03-15.

What conditions does trial NCT05411393 study?

This clinical trial studies the following conditions: Frailty, Rehabilitation, Frail Elderly, Occupational Therapy, Functional Status.

What interventions are being tested in trial NCT05411393?

The interventions under investigation include: ADL-enhanced program (OTHER), Usual home health rehabilitation therapy (OTHER).

Who is sponsoring clinical trial NCT05411393?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05411393 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Frailty

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05411393's enrollment target sits among peer trials

47 31st of 48 higher than 18 of 48 other Frailty trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Frailty trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03313011 · 47 participants

    The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

  • NCT03467516 · 47 participants · Phase 2

    Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

  • NCT03886662 · 47 participants · Phase 1

    A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

  • NCT04013802 · 47 participants · Phase 1

    TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05411393, the US trial registry maintained by the National Library of Medicine. NCT05411393 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.